naltrexone has been researched along with Necrosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dehpour, AR; Emamgholipour, S; Golestani, A; Hosseini-Fard, SR | 1 |
| Donahue, R; McLaughlin, PJ; Zagon, IS | 1 |
| Klocek, MS; McLaughlin, PJ; Sassani, JW; Zagon, IS | 2 |
| McLaughlin, PJ; Rogosnitzky, M; Zagon, IS | 1 |
| Martone, C; Perli, D; Rapose, A | 1 |
| McLaughlin, PJ; Zagon, IS | 1 |
| Amanpour, S; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Jabehdar-Maralani, P; Mirkhani, SH; Shafaroodi, H; Tavakoli, S | 1 |
| Hulse, GK; McCallum, D; Morris, N; O'neil, G; Smit, W; Stalenberg, V; Tait, RJ | 1 |
| Klocek, MS; Mauger, DT; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Gutiérrez Mora, E; Lozano Polo, JL; Martínez Pérez, V; Santamaría Gutiérrez, J; Vada Sánchez, J; Vallejo Correas, JA | 1 |
| Lopez, J; Naujokat, P; Toledo-Pereyra, LH; Walters, W; Xavier, R | 1 |
1 trial(s) available for naltrexone and Necrosis
| Article | Year |
|---|---|
[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection].
Topics: Adult; Female; Hepatitis C; Humans; Liver; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Necrosis; Prospective Studies; Substance Abuse, Intravenous; Transaminases | 1997 |
11 other study(ies) available for naltrexone and Necrosis
| Article | Year |
|---|---|
Naltrexone protects against BDL-induced cirrhosis in Wistar rats by attenuating thrombospondin-1 and enhancing antioxidant defense system via Nrf-2.
Topics: Animals; Antioxidants; Bile Ducts; Ligation; Liver; Liver Cirrhosis; Male; NADPH Oxidase 1; Naltrexone; Necrosis; Rats; Rats, Wistar; Thrombospondin 1; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2022 |
Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer.
Topics: Apoptosis; Cell Cycle; Female; Gene Expression Regulation, Neoplastic; Humans; Naltrexone; Narcotic Antagonists; Necrosis; Neoplasm Proteins; Opioid Peptides; Ovarian Neoplasms; Receptors, Opioid; Up-Regulation | 2013 |
Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.
Topics: Administration, Topical; Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; DNA Replication; Drug Therapy, Combination; Epithelium, Corneal; Hypoglycemic Agents; Insulin; Intraocular Pressure; Male; Naltrexone; Narcotic Antagonists; Necrosis; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Time Factors; Wound Healing | 2009 |
Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; DNA Replication; Epidermal Cells; Epidermis; Imiquimod; Mice; Mice, Inbred C57BL; Mice, Nude; Naltrexone; Narcotic Antagonists; Necrosis; Nucleic Acid Synthesis Inhibitors; Receptors, Opioid; Up-Regulation | 2010 |
Naltrexone-induced Nicolau syndrome masquerading as cutaneous abscess.
Topics: Abscess; Debridement; Diagnosis, Differential; Drug Eruptions; Female; Humans; Injections, Intramuscular; Middle Aged; Naltrexone; Narcotic Antagonists; Necrosis; Skin; Subcutaneous Tissue; Syndrome | 2012 |
Opioids and the apoptotic pathway in human cancer cells.
Topics: Annexin A5; Apoptosis; Cell Adhesion; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Etorphine; Growth Substances; Humans; In Situ Nick-End Labeling; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Necrosis; Neoplasms; Tumor Cells, Cultured | 2003 |
Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cholestasis, Intrahepatic; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Naltrexone; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2005 |
Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humans.
Topics: Biocompatible Materials; Drug Implants; Female; Fibrosis; Foreign-Body Reaction; Heroin Dependence; Humans; Male; Microspheres; Naltrexone; Narcotic Antagonists; Necrosis; Polyesters; Skin; Subcutaneous Fat; Time Factors | 2005 |
Corneal safety of topically applied naltrexone.
Topics: Administration, Topical; Animals; Apoptosis; Cell Count; Cornea; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelium, Corneal; Male; Naltrexone; Narcotic Antagonists; Necrosis; Rats; Rats, Sprague-Dawley | 2006 |
Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
Topics: Administration, Topical; Animals; Apoptosis; Cell Count; Cornea; Corneal Ulcer; Diabetes Mellitus, Experimental; DNA; Dose-Response Relationship, Drug; Epithelium, Corneal; Male; Naltrexone; Narcotic Antagonists; Necrosis; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Wound Healing | 2007 |
Protective effect of nalmefene and naloxone on the ischemically damaged small bowel.
Topics: Animals; Intestine, Small; Ischemia; Mesenteric Arteries; Naloxone; Naltrexone; Narcotic Antagonists; Necrosis; Rats; Rats, Inbred Strains; Time Factors | 1991 |